Cost-effective but clinically inappropriate: New NICE intervention thresholds in osteoporosis (Technology Appraisal 464)
Cost-effective but clinically inappropriate: New NICE intervention thresholds in osteoporosis (Technology Appraisal 464)
Purpose: to comment on the latest technology appraisal of the National Institute for Clinical Excellence (NICE) in osteoporosis.
Methods: review of NICE Technology Appraisal (TA464) on bisphosphonate use in osteoporosis.
Results: the NICE appraisal on bisphosphonate use in osteoporosis indicates that treatment with oral bisphosphonates may be instituted at a FRAX 10-year probability of major osteoporotic fracture above 1%. Implementation would mean that all women aged 50 years or older are deemed eligible for treatment, a position that would increase the burden of rare long-term side effects across the population.
Conclusion: cost-effectiveness thresholds for low-cost interventions should not be used to set intervention thresholds but rather to validate the implementation of clinically driven intervention thresholds.
1511-1513
Harvey, N.C.
ce487fb4-d360-4aac-9d17-9466d6cba145
McCloskey, E.
5211de37-303a-42f8-b24b-00c475264f78
Kanis, J.A.
55c6bd2c-d653-48de-b4b9-29fe280fb00f
Compston, J.
b64c0d0e-97dd-44c8-97ba-f756f0bc966d
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
July 2018
Harvey, N.C.
ce487fb4-d360-4aac-9d17-9466d6cba145
McCloskey, E.
5211de37-303a-42f8-b24b-00c475264f78
Kanis, J.A.
55c6bd2c-d653-48de-b4b9-29fe280fb00f
Compston, J.
b64c0d0e-97dd-44c8-97ba-f756f0bc966d
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Harvey, N.C., McCloskey, E., Kanis, J.A., Compston, J. and Cooper, C.
(2018)
Cost-effective but clinically inappropriate: New NICE intervention thresholds in osteoporosis (Technology Appraisal 464).
Osteoporosis International, .
(doi:10.1007/s00198-018-4505-x).
Abstract
Purpose: to comment on the latest technology appraisal of the National Institute for Clinical Excellence (NICE) in osteoporosis.
Methods: review of NICE Technology Appraisal (TA464) on bisphosphonate use in osteoporosis.
Results: the NICE appraisal on bisphosphonate use in osteoporosis indicates that treatment with oral bisphosphonates may be instituted at a FRAX 10-year probability of major osteoporotic fracture above 1%. Implementation would mean that all women aged 50 years or older are deemed eligible for treatment, a position that would increase the burden of rare long-term side effects across the population.
Conclusion: cost-effectiveness thresholds for low-cost interventions should not be used to set intervention thresholds but rather to validate the implementation of clinically driven intervention thresholds.
Text
NICE BP editorial OSIN R1
- Accepted Manuscript
More information
Accepted/In Press date: 19 January 2018
e-pub ahead of print date: 8 June 2018
Published date: July 2018
Identifiers
Local EPrints ID: 422052
URI: http://eprints.soton.ac.uk/id/eprint/422052
ISSN: 0937-941X
PURE UUID: c27bcdd5-fd9b-4db3-9a7f-336f0a90cb94
Catalogue record
Date deposited: 13 Jul 2018 16:30
Last modified: 18 Mar 2024 05:03
Export record
Altmetrics
Contributors
Author:
E. McCloskey
Author:
J.A. Kanis
Author:
J. Compston
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
